Adelphi Research
Anne Vandevoorde-Bonser has a diverse work experience spanning over 25 years. Anne is currently working as a Research Director at Adelphi Research Global, where they generate strategic insights and conducts innovative market research to support decision-making in the bio-pharma industry. Prior to this, Anne worked as a Global Insights & Analytics Director at Ipsen. Anne has also held various roles at Bristol Myers Squibb, including Insights & Analytics Director for Europe - Diabetes & CV, Insight & Analytics Associate Director for Europe - Immuno-Inflammation / CNS, and Market Research Manager for Europe - CNS. Anne has extensive experience in improving business results through insights and analytics and launching new brands. Anne also has a background in sales and field force management.
Anne Vandevoorde-Bonser completed a Certificate of Advanced English from the University of Cambridge in 1996. The duration of this program is unclear. Additionally, Anne earned a Doctorate in Pharmacy with Honors from the University of Strasbourg. The specific start and end years of this degree are not provided. No information is given indicating the completion of any other degrees or further education.
This person is not in any offices
Adelphi Research
Adelphi Research is a global healthcare market insight consultancy that navigates brand challenges, informs decisions and inspires stakeholders to take action. Established for over 30 years, we help pharma and healthcare companies to answer the complex business questions that underpin brand success. At Adelphi Research, time never stands still. We continue to innovate, evolve and grow. With headquarters near Manchester, UK and Doylestown, PA, USA, we have a diverse team of over 100 in-house consultants, research professionals, advanced analytics specialists and operational experts. Adelphi Research is part of Adelphi Group, an Omnicom Group Inc. company. We offer a unique, multi-perspective approach through leveraging the knowledge and talent in our sister companies which include medical communications, real world evidence, values and outcomes businesses.